Overview of Dr. Latham
Dr. Alicia Latham is a cancer geneticist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from the Medical University of South Carolina College of Medicine, her residency at Self Regional Healthcare, and her fellowship at Memorial Sloan Kettering Cancer Center. She is double board-certified in family medicine and medical genetics, and specializes in cancer genetics/cancer risk assessment. She is experienced in cancer genetics, hereditary breast/ovarian cancer, lynch syndrome, predictive genetic testing, and clinical genetics.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Medical Genetics and Genomics, 2016 - 2018
Self Regional Healthcare/GreenwoodResidency, Family Medicine, 2013 - 2016
Medical University of South CarolinaClass of 2013
Certifications & Licensure
FL State Medical License 2021 - Present
CT State Medical License 2023 - 2025
NJ State Medical License 2019 - 2025
NY State Medical License 2018 - 2025
SC State Medical License 2014 - 2019- American Board of Family Medicine Family Medicine
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Allen S. Lichter Endowed Merit Award Conquer Cancer Foundation of ASCO, 2018
Publications & Presentations
PubMed
- 1 citationsLynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer.Catherine A O'Connor, Emily Harrold, David Lin, Henry Walch, Andrea Gazzo
JAMA Oncology. 2024-11-01 - 1 citationsUniversal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.Ozge Ceyhan-Birsoy, Elise Fiala, Satshil Rana, Margaret Sheehan, Jennifer Kennedy
Haematologica. 2024-10-01 - 1 citationsBenign splenic lesions in BAP1-tumor predisposition syndrome: a case series.Joao Miranda, Priya Dave, Yelena Kemel, Rania Sheikh, Grace Zong
European Journal of Human Genetics. 2024-08-01
Lectures
- Prevalence and Clinical Implications of Mismatch Repair Proficient Colorectal Cancer in Lynch Syndrome Patients, Presidential Plenary PresentationCollaborative Group of the Americas on Inherited Colorectal Cancer - 11/4/2020
- Characterization and clinical outcomes of mismatch repair deficient (dMMR) small bowel adenocarcinoma (SBA).2019 ASCO Annual Meeting - 6/1/2019
- Pan-cancer microsatellite instability to predict for presence of Lynch syndrome. Tumor Testing in Precision Oncology: From Heredity to Counseling to Implementation2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
More Than BRCA: The Other Life-Threatening Breast Cancer Gene Mutation to Be Aware OfOctober 4th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
